Novel Insights into the Protective Properties of ACTH(4-7)PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia–Reperfusion in Rats
by
Ivan B. Filippenkov 1,*
, Vasily V. Stavchansky 1, Alina E. Denisova 2, Vadim V. Yuzhakov 3, Larisa E. Sevan’kaeva 3, Olga Y. Sudarkina 1, Veronika G. Dmitrieva 1, Leonid V. Gubsky 2, Nikolai F. Myasoedov 1, Svetlana A. Limborska 1 and Lyudmila V. Dergunova 1
Ivan B. Filippenkov 1,*, Vasily V. Stavchansky 1, Alina E. Denisova 2, Vadim V. Yuzhakov 3, Larisa E. Sevan’kaeva 3, Olga Y. Sudarkina 1, Veronika G. Dmitrieva 1, Leonid V. Gubsky 2, Nikolai F. Myasoedov 1, Svetlana A. Limborska 1 and Lyudmila V. Dergunova 1
1
Institute of Molecular Genetics, Russian Academy of Sciences, 123182 Moscow, Russia
2
Pirogov Russian National Research Medical University, Federal Center of Cerebrovascular Pathology and Stroke, Ministry of Health Care of Russian Federation, 117342 Moscow, Russia
3
A. Tsyb Medical Radiological Research Center–Branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, 249031 Obninsk, Russia
*
Author to whom correspondence should be addressed.
Genes 2020, 11(6), 681; https://doi.org/10.3390/genes11060681
Received: 16 May 2020 / Revised: 9 June 2020 / Accepted: 18 June 2020 / Published: 22 June 2020
(This article belongs to the Special Issue Disentangling Mechanisms of Genomic Regulation of Cell Functions at the Gene Level)
Cerebral ischaemia is the most common cause of impaired brain function. Biologically active peptides represent potential drugs for reducing the damage that occurs after ischaemia. The synthetic melanocortin derivative, ACTH(4-7)PGP (Semax), has been used successfully in the treatment of patients with severe impairment of cerebral blood circulation. However, its molecular mechanisms of action within the brain are not yet fully understood. Previously, we used the transient middle cerebral artery occlusion (tMCAO) model to study the damaging effects of ischaemia–reperfusion on the brain transcriptome in rats. Here, using RNA-Seq analysis, we investigated the protective properties of the Semax peptide at the transcriptome level under tMCAO conditions. We have identified 394 differentially expressed genes (DEGs) (>1.5-fold change) in the brains of rats at 24 h after tMCAO treated with Semax relative to saline. Following tMCAO, we found that Semax suppressed the expression of genes related to inflammatory processes and activated the expression of genes related to neurotransmission. In contrast, ischaemia–reperfusion alone activated the expression of inflammation-related genes and suppressed the expression of neurotransmission-related genes. Therefore, the neuroprotective action of Semax may be associated with a compensation of mRNA expression patterns that are disrupted during ischaemia–reperfusion conditions.
View Full-Text
Keywords:
tMCAO; mRNA expression; RNA-Seq; synthetic melanocortin derivative ACTH(4-7)PGP (Semax); peptide regulation
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
- Supplementary File 1:
ZIP-Document (ZIP, 7473 KB)
MDPI and ACS Style
Filippenkov, I.B.; Stavchansky, V.V.; Denisova, A.E.; Yuzhakov, V.V.; Sevan’kaeva, L.E.; Sudarkina, O.Y.; Dmitrieva, V.G.; Gubsky, L.V.; Myasoedov, N.F.; Limborska, S.A.; Dergunova, L.V. Novel Insights into the Protective Properties of ACTH(4-7)PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia–Reperfusion in Rats. Genes 2020, 11, 681.
Show more citation formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
Search more from Scilit
